Press Release Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome Aug 28
Press Release Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million Aug 28
Press Release Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results Aug 14